false

Cellular Therapy Service

Cellular therapy uses immune cells to target cancer, autoimmune disorders, or other serious diseases. We’re at the forefront of developing and delivering new and approved forms of cellular therapies. Our patients have access to the latest, research-driven treatments, including both FDA-approved therapies and clinical trials.

Three researchers are gathered around a computer workstation in a laboratory setting.

full-fill

primary
phone
855-776-4224

Call the Mass General Brigham Cancer Institute

8557764224

Treatment driven by research

At Mass General Brigham Cancer Institute, we bring advances in cell therapy directly into patient care. As leaders in the field, our clinicians and researchers work together to accelerate progress and expand treatment options for people with cancer and other complex and serious diseases, even those that aren’t cancer.

Our long-term goal is to cure disease, while supporting patients today through safe, carefully monitored therapies. We spread these advancements throughout the medical community by providing regular education events in cellular therapy.

center
tertiary
internal-arrow
Part of the Cancer Institute
/content/unified-xwalk/en/services/cancer

Our approach to care

Our approach focuses on personalized treatment, close collaboration, and timely access to emerging therapies.
A male scientist in a white lab coat carefully lifts a vertical rack of frozen sample containers from a cold storage unit.
Compassionate, patient-centered care
You are at the center of every treatment decision. We work closely with you to find the right treatment for your needs, always taking time to discuss your questions, preferences, and goals.
Bringing breakthroughs from the lab to the bedside

We deliver research-based cellular therapies directly to our patients. Our current offerings and areas of active study include:

  • CAR T-cell therapy for lymphoma and multiple myeloma
  • Clinical trials evaluating CAR T-cell therapy for glioblastoma
  • Tumor-infiltrating lymphocyte (TIL) therapy for melanoma

Cancer clinical trials and research

Our research is shaping the future of cancer care. We offer access to clinical trials and emerging therapies, including treatments that may not yet be widely available. Eligibility depends on a person’s diagnosis, treatment history, and more. Explore our research and clinical trials or talk with your care team to learn about available options.
A medical professional speaks with a patient seated in a hospital chair.
tertiary
external
Explore our cancer research

Learn how cancer research informs patient care

https://research.massgeneralbrigham.org/en/institutes-centers/cancer-institute-research
tertiary
external
Search clinical trials
https://research.massgeneralbrigham.org/en/institutes-centers/cancer-institute-research/cancer-clinical-trials

Patient resources and support

We offer a range of resources to support patients and caregivers before, during, and after cancer treatment. These services address physical, emotional, and practical needs and are available alongside your medical care.
tertiary
internal-arrow
View all patient resources
/content/unified-xwalk/en/services/cancer/resources

Contact the Cancer Institute

Call us to speak with a team member who can help you understand your options and guide you to the care that is right for you. With locations throughout New England and support for patients traveling from outside the United States, we make it easier to access coordinated, expert care.
primary
phone
855-776-4224

Call the Mass General Brigham Cancer Institute

8557764224
secondary
internal
International Patient Services

Contact International Patient Services

/content/unified-xwalk/en/patients-visitors/international/for-patients/contact